Looking for a clinical trial that's right for you?
Find a TrialUCI Health, your source for clinical trials
UCI Health has Orange County’s largest clinical trials program, with 1,000-plus trials and over 3,000 patients enrolled in the past year. By participating in a clinical trial, you help shape the future of medicine. Help us discover and cure!
What are clinical trials?
Clinical trials evaluate the effects of new interventions on health.
Featured Trials
Phase 3 Study of ALXN2220 versus Placebo in Adults with ATTR-CM
This clinical study tests the safety and effectiveness of ALXN2220 for treating transthyretin amyloid cardiomyopathy (ATTR-CM). It compares the drug to a placebo in a Phase 3 trial.
A research study to look at how ziltivekimab works compared to placebo in people with heart
This clinical trial checks if ziltivekimab provides better treatment and outcomes for people with heart failure and inflammation.
A Study to Evaluate the Safety and Efficacy of KPI-012 in PCED
This clinical trial evaluates the safety and efficacy of KPI-012 ophthalmic solution in participants with persistent corneal epithelial defect (PCED).
Sangamo Fabry LTFU Study Protocol ST-920-LT01
A long-term follow-up of Fabry disease patients treated with ST-920, an rAAV2/6 gene therapy for alpha-galactosidase A.
A Phase II Study of ATR Inhibition in Advanced PD-(L)1-Refractory Merkel Cell Carcinoma
This clinical trial Phase 2 trial tests M1774 alone or with avelumab for patients not responding to anti-PD(L)1 therapy, comparing effectiveness and survival outcomes.
PhI BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lung Cancer
This clinical trial investigates Nivolumab with chemo-immunotherapy for new Primary Mediastinal B-cell Lymphoma, aiming to improve outcomes.
Learn more about clinical trials at UCI Health
Explore valuable resources and support for all aspects of clinical trials at UCI health
UCI Research News
UCI Health enrolls patient in first U.S. study of medical device for erectile dysfunction
UCI Health has opened the first U.S. clinical trial of a novel radiofrequency device designed to treat erectile dysfunction (ED). Men's health specialist Dr. Faysal A. Yafi is leading the study of Vertica®, a device, designed and manufactured by Ohh-Med Ltd.
2024 Cancer Center Scientific Retreat
This retreat on Friday, November 8, 2024 is open to CFCCC members, clinicians, DOT leaders, shared resource teams, CHOC partners, community equity board members, established community partners, MET trainees, staff, postdoctoral trainees, graduate students and undergraduate students in cancer-related research labs.
Advancing regenerative medicine therapies
University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility’s grand opening in Hewitt Hall’s basement on the UC Irvine campus.